Profil
Daniel T.
Chiu is the founder of Cellectricon AB, founded in 2000, and MiCareo, Inc., founded in 2011.
Dr. Chiu currently holds the position of Independent Director at Fluicell AB since 2017 and has been a Professor at the University of Washington since 2006.
Dr. Chiu completed a doctorate degree at Harvard University and an undergraduate degree at Stanford University.
Aktive Positionen von Daniel T. Chiu
| Unternehmen | Position | Beginn |
|---|---|---|
| FLUICELL AB | Direktor/Vorstandsmitglied | 01.01.2017 |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 29.10.2009 |
Ehemalige bekannte Positionen von Daniel T. Chiu
| Unternehmen | Position | Ende |
|---|---|---|
MiCareo, Inc.
MiCareo, Inc. BiotechnologyHealth Technology Provides tools for the analysis of rare cells | Gründer | - |
Cellectricon AB
Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Provides cell-based screening services to accelerate drug discovery | Gründer | - |
Ausbildung von Daniel T. Chiu
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Cellectricon AB
Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Provides cell-based screening services to accelerate drug discovery | Commercial Services |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MiCareo, Inc.
MiCareo, Inc. BiotechnologyHealth Technology Provides tools for the analysis of rare cells | Health Technology |
Fluicell AB
Fluicell AB BiotechnologyHealth Technology Provides fluid platforms for multi-functional pipettes for cell-based pharmacology research | Health Technology |
















